About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Notice of Annual General Meeting
April 24, 2018
Click here to read more
Post navigation
Previous Post
Investor Presentation April 2018
Next Post
CEO Roadshow Presentation
Related Posts
Avecho reaches two-year stability milestone for its CBD softgel capsule
June 22, 2023
June 22, 2023
Phosphagenics’ PHN Trial Completes Enrolment and Dosing
December 17, 2015
Appendix 4E and 2016 Annual Financial Report
February 28, 2017